Rua Bioscience Archives | Page 3 of 5 | Cannabiz

Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience

by Steve Jones and Martin Lane February 7, 2024November 25, 2024

Breathe Life Sciences, a subsidiary of ASX-listed Bioxyne, has received a Good Manufacturing Practice licence from […]

Company news: Rua Bioscience; IDT Australia; Emyria; Elixinol Wellness; Neurotech; Hygrovest; Releaf Group/ICCM; Botanix

by Martin Lane August 30, 2023April 30, 2024

Company news: MedReleaf; Vitura Health; MGC Pharma; Rua Bioscience

by Martin Lane April 13, 2023April 30, 2024

Rua Bioscience vows to continue product supply despite taking axe to local manufacturing

by Steve Jones March 27, 2023April 30, 2024

Rua Bioscience appoints new CEO and board chair

by Martin Lane February 13, 2023April 30, 2024

Company news: Bod; Incannex; Medlab; Rua Bioscience; Emyria

by Martin Lane October 20, 2022April 29, 2024

Company news: Cann Group; Cronos; Releaf Group; Rua Bioscience; Incannex

by Martin Lane October 12, 2022April 29, 2024

Financial results: Avecho; AusCann; Zelira; Elixinol; Cann Group; Incannex; Creso Pharma; Medlab; Rua Bioscience

by Steve Jones and Martin Lane September 1, 2022April 29, 2024

Ecofibre; LGP; Creso Pharma; Rua Bioscience; The Pain Clinic; MGC Pharma

by Martin Lane July 28, 2022April 29, 2024

Company news: Creso Pharma; Wellnex Life; Zyus Life Sciences; Emyria; MGC Pharma; Rua Bioscience

by Martin Lane July 21, 2022April 29, 2024